(18)F-misonidazole PET imaging of hypoxia in micrometastases and macroscopic xenografts of human non-small cell lung cancer: a correlation with autoradiography and histological findings
- PMID: 23526377
- PMCID: PMC3601474
(18)F-misonidazole PET imaging of hypoxia in micrometastases and macroscopic xenografts of human non-small cell lung cancer: a correlation with autoradiography and histological findings
Abstract
The objective of this study was to determine whether (18)F-misonidazole could detect hypoxia in macroscopic and microscopic tumors in mice. In nude mice, subcutaneous xenografts and peritoneal metastases were generated utilizing human non-small cell lung cancer A549 and HTB177 cells. Animals were co-injected with (18)F-misonidazole, pimonidazole and bromodeoxyuridine, and tumor perfusion was assessed by Hoechst 33342 injection. The intratumoral distribution of (18)F-misonidazole was determined by micro-PET scan and autoradiography. Pimonidazole, bromodeoxyuridine and Hoechst 33342 were detected by immunohistochemistry on the autoradiography sections. Submillimeter micrometastases found to be severely hypoxic. In both peritoneal metastases and subcutaneous xenografts models, PET images displayed significant (18)F-misonidazole uptake, and its distribution was non-uniform in these macroscopic subcutaneous tumors. In frozen sections, digital autoradiography and immunohistochemistry revealed similar distributions of (18)F-misonidazole, pimonidazole and glucose transporter-1, in both microscopic and macroscopic tumors. Bromodeoxyuridine stained-positive proliferative regions were well perfused, as judged by Hoechst 33342, and displayed low (18)F-misonidazole accumulation. (18)F-misonidazole uptake was low in tumor stroma and necrotic zones as well. Microscopic non-small cell lung cancer metastases are severely hypoxic. (18)F-misonidazole PET is capable to image hypoxia noninvasively not only in macroscopic tumors but also in micrometastases growing in mice. Accordingly, (18)F-misonidazole may be a promising agent to detect the burden of micrometastatic diseases.
Keywords: 18F-misonidazole; Micrometastasis; PET; autoradiography; hypoxia.
Figures





Similar articles
-
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.J Nucl Med. 2012 Aug;53(8):1262-8. doi: 10.2967/jnumed.111.098087. Epub 2012 Jun 19. J Nucl Med. 2012. PMID: 22717978
-
(18)F-fluoromisonidazole PET reveals spatial and temporal heterogeneity of hypoxia in mouse models of human non-small-cell lung cancer.Future Oncol. 2015;11(20):2841-9. doi: 10.2217/fon.15.205. Epub 2015 Sep 11. Future Oncol. 2015. PMID: 26361064
-
Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1803-11. doi: 10.1007/s00259-008-0772-7. Epub 2008 Apr 18. Eur J Nucl Med Mol Imaging. 2008. PMID: 18421457
-
High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia.J Nucl Med. 2010 Apr;51(4):632-8. doi: 10.2967/jnumed.109.071233. J Nucl Med. 2010. PMID: 20351353 Free PMC article.
-
Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.Radiother Oncol. 2006 Aug;80(2):157-64. doi: 10.1016/j.radonc.2006.07.023. Epub 2006 Aug 14. Radiother Oncol. 2006. PMID: 16905213
Cited by
-
Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.Oncotarget. 2017 Jun 27;8(26):43536-43542. doi: 10.18632/oncotarget.16647. Oncotarget. 2017. PMID: 28402949 Free PMC article.
-
Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice.BMC Cancer. 2015 Oct 16;15:716. doi: 10.1186/s12885-015-1731-x. BMC Cancer. 2015. PMID: 26475304 Free PMC article.
-
Hypoxia and the Tumor Microenvironment.Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211036304. doi: 10.1177/15330338211036304. Technol Cancer Res Treat. 2021. PMID: 34350796 Free PMC article. Review.
-
(18)F-fluorodeoxyglucose uptake and tumor hypoxia: revisit (18)f-fluorodeoxyglucose in oncology application.Transl Oncol. 2014 Apr;7(2):240-7. doi: 10.1016/j.tranon.2014.02.010. Epub 2014 Mar 4. Transl Oncol. 2014. PMID: 24699008 Free PMC article.
-
Positron emission tomography to assess hypoxia and perfusion in lung cancer.World J Clin Oncol. 2014 Dec 10;5(5):824-44. doi: 10.5306/wjco.v5.i5.824. World J Clin Oncol. 2014. PMID: 25493221 Free PMC article. Review.
References
-
- Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al., editors. National Cancer Institute. Bethesda, MD: 2011. SEER Cancer Statistics Review, 1975-2008. http://seer.cancer.gov/csr/1975_2008/, posted to the SEER web site.
-
- Soon YY, Stockler MR, Askie LM, Boyer MJ. Duration of Chemotherapy for Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials. J. Clin. Oncol. 2009;27:3277–83. - PubMed
-
- Höckel M, Schlenger K, Knoop C, Vaupel P. Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements. Cancer Res. 1991;51:6098–102. - PubMed
-
- Höckel M, Knoop C, Schlenger K, Vorndran B, Knapstein PG, Vaupel P. Intratumoral pO2 histography as predictive assay in advanced cancer of the uterine cervix. Adv Exp Med Biol. 1994;345:445–50. - PubMed
LinkOut - more resources
Full Text Sources